Previously, we reported a reduction in eNOS expression (Mahmoud et al., 2016; Chen et al., 2018) and excessive levels of CCL28/CCR10 in both patients with T2DM and diabetic mice (Chen et al., 2022). This evidence concerns the gene NOS3 and type 2 diabetes mellitus.